Year:  2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 

QPP Measure #ACQR11

High Intensity Statin for patients with NSTEMI-ACS

High intensity statin (rosuvastatin 20-40 mg or atorvastatin 80mg) should be initiated or continued in all patients with NSTEMI-ACS and no contraindications

Submission Methods: Registry

There are no codes for this QPP measure.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.